The University of Texas Health Science Center at San Antonio: Insulin Resistance trials

The registry lists 11 Insulin Resistance studies with The University of Texas Health Science Center at San Antonio as lead sponsor. 2 are open to participants now and 6 have results posted.

Early Phase 1 2Phase 2 4Phase 4 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Genetic of Skeletal Muscle Insulin ResistanceRecruitingNCT07780513Not applicable
• Quantifying Hepatic Mitochondrial Fluxes in HumansRecruitingNCT05305287Phase 4
• Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DMCompletedNCT02981069Phase 4Results posted
• The Role of TLR4 on Lipid-induced Insulin ResistanceCompletedNCT02321111Phase 2Results posted
• The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic SubjectsTerminatedNCT02267317Phase 2Results posted
• Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)CompletedNCT02127125Phase 2Results posted
• Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)CompletedNCT02124759Phase 2Results posted
• Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/ActionCompletedNCT01439854Not applicableResults posted
• Long-Term Sequelae of SARS-COV-2 Infection: Diabetes MellitusCompletedNCT05867017
• Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DMCompletedNCT05093517Early Phase 1
• Effect of Physiologic Hyperglucogonemia on Adipocyte MetabolismCompletedNCT04300049Early Phase 1